Document is current
Any future updates will be listed below
-
Authors
Abdulreda, Midhat H.
Berman, Dora M.
Shishido, Alexander
Martin, Christopher
Hossameldin, Maged
Tschiggfrie, Ashley
Hernandez, Luis F.
Hernandez, Ana
Ricordi, Camillo
Parel, Jean-Marie
Jankowska-Gan, Ewa
Burlingham, William J.
Arrieta-Quintero, Esdras A.
Perez, Victor L.
Kenyon, Norma S.
Berggren, Per-Olof
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK116241)
Stanley J. Glaser Foundation (UM SJG2016-2)
National Institute of Allergy and Infectious Diseases (R56AI130330)
- License Information
-
More Information
Article History
Received: 13 July 2018
Accepted: 14 December 2018
First Online: 31 January 2019
Duality of interest
: P-OB is cofounder and CEO of Biocrine, an unlisted biotech company that is using the anterior chamber of the eye technique as a research tool. MHA is consultant for the same company. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.
Free to read: This content has been made available to all.
